ANI Pharmaceuticals Inc (ANIP)
Debt-to-equity ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 428,530 | 430,798 | 455,760 | 451,963 | 432,749 | 454,711 | 434,472 | 339,482 | 338,540 | 336,675 | 336,958 | 346,094 | 358,740 | 191,403 | 191,917 | 203,712 | 195,700 | 195,100 | 191,344 | 201,171 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $428,530K
= 0.00
The debt-to-equity ratio of ANI Pharmaceuticals Inc has consistently remained at 0.00 from March 2020 to December 2024, indicating that the company has no debt and its financing is primarily sourced from equity. This suggests a conservative financial structure, as the absence of debt implies lower financial risk and less reliance on borrowing to fund operations or growth. ANI Pharmaceuticals Inc's stable debt-to-equity ratio over the years indicates strong financial stability and a healthy balance between debt and equity in its capital structure. Additionally, a consistently low debt-to-equity ratio may indicate efficient utilization of equity capital and sound management of financial resources.
Peer comparison
Dec 31, 2024